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Inhibitory glycine receptors (GlyRs) regulate motor
coordination and sensory signal processing in spinal
cord and other brain regions. GlyRs are pentameric
proteins composed of membrane-spanning  and 
subunits. Here, site-directed mutagenesis combined
with homology modeling based on the crystal struc-
ture of the acetylcholine binding protein identified
key ligand binding residues of recombinant homo-
oligomeric 1 and heterooligomeric 1 GlyRs. This
disclosed two highly conserved, oppositely charged
residues located on adjacent subunit interfaces as
being crucial for agonist binding. In addition, the 
subunit was found to determine the ligand binding
properties of heterooligomeric GlyRs. Expression of
an 1 tandem construct and affinity purification of
metabolically labeled GlyRs confirmed a subunit stoi-
chiometry of 23. Because the  subunit anchors
GlyRs at synaptic sites, our results have important
implications for the biosynthesis, clustering, and
pharmacology of synaptic GlyRs.
Introduction
A precise balance between neuronal excitation and in-
hibition is crucial for proper functioning of the CNS.
Disturbance of neuronal excitation-inhibition homeo-
stasis results in severe pathological phenotypes, such
as excitotoxic neurodegeneration, epilepsy, muscular
spasticity, and mental retardation (Zoghbi et al., 2000).
The amino acid glycine regulates neuronal activity by
activating two classes of phylogenetically and structur-
ally distinct ligand-gated ion channels, chloride-perme-
able inhibitory glycine receptors (GlyRs), which are
members of the pentameric Cys-loop receptor super-
family, and cation-selective excitatory N-methyl-D-
aspartate receptors (NMDARs), which belong to the
tetrameric ionotropic glutamate receptor family (Cull-
Candy et al., 2001; Grutter and Changeux, 2001). Both*Correspondence: neurochemie@mpih-frankfurt.mpg.dereceptor classes are crucially involved in brain function
and malfunction, with their subunit compositions deter-
mining their specific functional properties and subcellu-
lar localizations (Cull-Candy et al., 2001; Laube et al.,
2002).
GlyR-mediated synaptic inhibition in spinal cord and
brain stem is essential for the control of motor rhythm
generation, coordination of spinal reflex responses, and
processing of sensory signals (Legendre, 2001). Synap-
tically localized GlyR proteins are composed of two
types of homologous membrane-spanning subunits,
the 48 kDa α and the 58 kDa β subunits (reviewed in
Laube et al., 2002; Rajendra et al., 1997). Each subunit
consists of a large extracellular binding domain, four
transmembrane segments (M1–M4), and a long intra-
cellular loop between M3 and M4. The α subunits are
thought to contain major determinants of agonist and
antagonist binding and exist in four different isoforms
(α1–α4) encoded by regionally and developmentally
distinctly expressed genes (Harvey et al., 2004; Malosio
et al., 1991). The unique β subunit gene (Glrb) in con-
trast is transcribed at all developmental stages in many
regions of the mammalian CNS (Fujita et al., 1991; Ma-
losio et al., 1991). Upon heterologous expression, all
α subunits generate functional homooligomeric GlyRs
(Kuhse et al., 1995; Laube et al., 2002), which in vivo
are found extrasynaptically (Singer and Berger, 2000;
Takahashi et al., 1992). In contrast, the β subunit forms
channels only upon coassembly with α subunits at an
invariant stoichiometry (Bormann et al., 1993; Kuhse et
al., 1993). A hydrophobic sequence within the M3–M4
loop of the β subunit interacts with the receptor-anchor-
ing protein gephyrin (Meyer et al., 1995) and thereby
provides for synaptic clustering of heterooligomeric
GlyRs (Kneussel and Betz, 2000).
From cross-linking experiments with GlyR purified
from spinal cord, the subunit stoichiometry of heterooli-
gomeric GlyRs has been deduced to be 3α:2β (Lan-
gosch et al., 1988). Homo- and heterooligomeric GlyRs
differ in chloride conductance (Bormann et al., 1993)
and picrotoxinin sensitivity (Pribilla et al., 1992). UV
cross-linking of the radiolabeled antagonist strychnine
to GlyR purified from spinal cord produced a selective
labeling of α subunits, consistent with only the α and
not the β subunits contributing to ligand binding (Pfeif-
fer et al., 1982). Mutational analysis of homooligomeric
α1 GlyRs revealed several residues important for ago-
nist and/or antagonist interaction (reviewed in Brei-
tinger and Becker, 2002; Laube et al., 2002; Rajendra et
al., 1997). So far, an eventual contribution of the β sub-
unit to ligand binding has not been investigated.
Structure-function studies on other members of the
Cys-loop receptor family, such as nicotinic acetylcho-
line receptors (nAChRs), GABAA receptors (GABAARs),
and the 5-HT3 receptor, indicate that ligand binding
takes place at the interface between the N-terminal do-
mains of two adjacent subunits (Corringer et al., 2000).
This is consistent with crystallographic data on a ho-
mologous soluble acetylcholine binding protein (AChBP)
from the snail Lymnea stagnalis (Brookhaven Protein
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728Figure 1. Alignment and Structural Model of the Extracellular Domain of the Human GlyR α1 Subunit
(A) Partial sequence alignment of AChBP with the amino-terminal subdomains of the human GlyR α1 and β subunits, the human nAChR α7
subunit, the glutamate-gated chloride channel α subunit from C. elegans (GLUCLACE), and the human GABAAR subunits α1, β2, γ2, and ρ2.
Secondary structure elements found in AChBP are indicated above its sequence. Residues conserved throughout the superfamily are un-
derlain in dark gray, and partially conserved residues are underlain in light gray. Residues mutated in the GlyR α1 subunit are numbered
underneath the alignment. Amino acid residues located at the − side of the subunit interfaces are shown in blue, and residues located at
the + side are shown in green.
(B) Model of the extracellular domains of two adjacent GlyR α1 subunits (side view). Backbones of the subunits are illustrated in ribbon
representations (green, + side; blue, − side of the interface). Glycine was docked into the interface followed by energy minimization. Residues
thought to contribute to ligand recognition (yellow dots) were mutated.Data Bank entry 1I9B) (Brejc et al., 2001). In this penta- w
meric protein, residues from both sides of the subunit t
interface contribute to ligand binding, with the plus (+) d
side presenting loop elements, and the minus (−) side p
presenting β sheets, toward the interface. Since the A
AChBP displays up to 27% amino acid identity to the p
extracellular N-terminal domains of Cys-loop family p
members, it has been used as template in modeling of s
nAChR (Le Novere et al., 2002), GABAAR (Cromer et al., s
2002), GlyR (Laube et al., 2002), and 5HT3 receptor p
(Maksay et al., 2003) proteins. C
In the present study, electrophysiological and molec- t
ular modeling techniques were combined to explore the t
ligand binding sites of homo- and heterooligomeric (
GlyRs. Based on the crystal structure of the AChBP, c
models of the N-terminal domains of the α1 and β sub- C
unit were generated. Amino acid residues predicted to f
participate in ligand binding were mutated to reveal key d
residues implicated in agonist and antagonist binding. α
In contrast to previous reports in which the GlyR β sub- α
unit was suggested to have mainly a structural role in f
anchoring the receptor at postsynaptic sites (see Kuhse w
et al., 1995), here a major role of the β subunit in ligand S
binding is demonstrated. Furthermore, expression of a e
tandem α1β construct along with metabolic labeling l
analyses of recombinant GlyRs discloses the β subunit g
as major component of heterooligomeric GlyR proteins i
and establishes a subunit stoichiometry of 2α1:3β. Fi- n
nally, our results indicate a common mode of binding α
for the α-carboxylate and amino groups of amino acid p
neurotransmitters in different receptor families. m
Results
A
MStrategy for Mutational Analysis
Fof the GlyR 1 Subunit
tIn order to identify ligand binding residues of the GlyR,the crystal structure of the AChBP (Brejc et al., 2001)as taken as a template to generate a pentameric
hree-dimensional model of the extracellular N-terminal
omain of the human α1 subunit (Laube et al., 2002). A
artial alignment of the GlyR α1 subunit with the
ChBP sequence as chosen for homology modeling is
resented in Figure 1A; Figure 1B displays the modeled
olypeptide backbones of two neighboring GlyR α1
ubunits. The crystal structure of the AChBP was re-
olved with different ligands located in the binding
ocket formed at subunit interfaces (Brejc et al., 2001;
elie et al., 2004). Therefore, we decided to examine
he functional importance of residues homologous to
he AChBP positions, which lie within close distance
%6 Å) of the bound ligand and have been shown to
ontribute to ligand binding in different receptors of the
ys-loop family (Sixma and Smit, 2003). Specifically, we
ocused on the following charged and aromatic resi-
ues located either at the + side (α1Q155, α1E157,
1Y197, α1H201, α1F207, α1T208) or the − side (α1F63,
1R65, α1R119, α1R131, α1E172, α1D180) of the inter-
ace. Residues α1F159, α1K200, α1Y202, and α1T204,
hich were substituted previously (Rajendra et al., 1995;
chmieden et al., 1993; Vandenberg et al., 1992b), were
xcluded from our analysis. All amino acid side chains
isted above were exchanged to alanine, except for
lutamate 157, which was mutated to aspartate, since
ntroduction of an alanine at this position results in a
onfunctional receptor (Laube et al., 2000). Additionally,
1R65, α1R119, and α1R131 were isofunctionally re-
laced by lysine. The positions of the substitutions
ade are indicated in Figure 1B.
gonist Response Properties of Homomeric
utant 1 GlyRs
irst, we examined whether the mutations that were in-
roduced change agonist activation of the homooligo-meric α1 GlyR expressed in Xenopus laevis oocytes. All
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729α1 mutants generated functional receptors, with maxi-
mal glycine-induced current (Imax) values in the range
of 50–220 nA/mV, except α1E157D and α1F207A, which
produced low-current responses in the range of 10 nA/
mV even after application of 300 mM glycine. Wild-type
(wt) α1 GlyRs displayed a glycine EC50 value of 0.19 ±
0.05 mM (Table 1). Substitutions of the arginine resi-
dues α1R65 and α1R119 caused dramatic reductions
in apparent glycine affinity even upon isofunctional re-
placement (60- to 1300-fold; see Figure 2A). In the case
of the substitutions α1F63A, α1R65A, α1E157D, and
α1F207A, the EC50 value could only be estimated to be
R250 mM (Table 1), because glycine concentrations up
to 300 mM failed to saturate the current response. In
contrast, the following mutations had only small or no
effects on the dose response: αR131K and -A,
α1Q155A, α1E172A, α1D180A, α1Y197A, α1H201A, and
α1T208A. EC50 values were increased at most by 2- to
10-fold as compared to the wt α1 GlyR. This is consis-
tent with these amino acid residues playing only minor
roles in agonist binding and/or receptor function.
In addition to the full agonist glycine, we also tested
the partial agonist taurine. Mutants that showed only
low expression or had no effect on apparent glycine
affinity (α1H201A and α1F207A) were excluded from
analysis. All substitutions that affected the EC50 value
of glycine also reduced that of taurine (Table 1), indicat-
ing that the same amino acid residues are essential for
the binding of both agonists. To evaluate whether the
α1 subunit mutations introduced also might affect re-
ceptor gating, activation by the partial agonist taurine
was compared to that seen with the full agonist glycine
(Imaxtau/Imaxgly; see Table 1). Taurine is a low-efficacy
agonist; therefore, changes in gating properties should
become apparent as a reduction in the relative maxi-
mal inducible current (Colquhoun, 1998). Except for
α1R119A, all mutations examined showed a similar or
even higher relative maximal current with taurine than
the wt α1 GlyR (Table 1). Based on the theoretical
analysis of the interdependence of binding and gatingTable 1. Agonist and Antagonist Response Properties of Homooligomeric α1 GlyRs
cRNA Injected Glycine Taurine Strychnine
EC50 [mM] (n) nH EC50 [mM] (n) Imaxtau/Imaxgly (%) IC50 [nM] (n)
α1 wt 0.19 ± 0.05 (12) 2.4 ± 0.8 3.6 ± 1.6 (10) 25 ± 9 36 ± 10 (9)
α1F63A R250* (6) ND R300* (4) 20 ± 5 12000 ± 3000* (5)
α1R65K 41 ± 12* (5) 2.0 ± 0.3 58 ± 21* (5) 54 ± 7* 170 ± 80* (6)
α1R65A R250* (4) 2.2 ± 0.4 84 ± 20* (6) 83 ± 19* 160 ± 50* (4)
α1R119K 11 ± 4.1* (7) 1.8 ± 0.3 25 ± 19* (7) 37 ± 15 130 ± 70* (6)
α1R119A 27 ± 12* (5) 1.9 ± 0.1 67 ± 29* (7) 7.0 ± 1.0* 250 ± 120* (4)
α1R131K 2.3 ± 1.7* (5) 0.9 ± 0.2* 3.6 ± 1.8 (5) 57 ± 16* 830 ± 400* (6)
α1R131A 0.11 ± 0.09 (8) 1.6 ± 0.4 0.42 ± 0.16* (6) 65 ± 10* 13000 ± 3600* (8)
α1Q155A 2.5 ± 0.9* (9) 1.5 ± 0.3* 26 ± 5* (5) 26 ± 15 69 ± 23* (6)
α1E157D R250* (5) ND R300* (5) 96 ± 6* NI (5)
α1E172A 0.46 ± 0.33 (7) 1.9 ± 0.6 6.9 ± 0.9* (8) 31 ± 11 23 ± 12 (7)
α1D180A 0.49 ± 0.28* (7) 2.4 ± 0.4 6.0 ± 1.2 (5) 30 ± 11 26 ± 15 (7)
α1Y197A 0.45 ± 0.14* (6) 2.0 ± 0.9 4.9 ± 2.9 (5) 31 ± 17 37 ± 7 (7)
α1H201A 0.27 ± 0.16 (8) 2.1 ± 0.4 ND ND 69 ± 40 (7)
α1N203A 0.83 ± 0.21* (8) 2.5 ± 0.5 5.7 ± 1.7 (6) 42 ± 21 32 ± 18 (7)
α1F207A R250* (8) ND ND ND NI (4)
α1T208A 0.69 ± 0.25* (8) 1.7 ± 0.3 5.7 ± 1.5 (4) 58 ± 15* 2200 ± 800* (7)
All values are given as means ± SD. Asterisks indicate values that are significantly different (p < 0.01) from wt (Student's t test). ND, not
determined; NI, no inhibition; n, number of experiments.in receptor activation (Colquhoun, 1998), this indicatesthat mainly binding rather than gating mutants were
generated here.
Evaluation of Residues Important
for Antagonist Interaction
To determine whether the α1 residues mutated also
contribute to antagonist binding, inhibition curves for
strychnine were recorded. Strychnine is a competitive
antagonist of the GlyR, with an IC50 value of 36 ± 10
nM at wt α1 GlyRs. Six out of 16 of the amino acid
substitutions tested changed the IC50 value of strych-
nine >10-fold (Table 1 and Figure 2B). The mutations
α1E157D and α1F207A produced strychnine-insensi-
tive GlyRs that were not inhibited even at rather high
strychnine concentrations (%500 M). A strongly re-
duced inhibition by strychnine (330-fold) was also ob-
served for the α1F63A replacement. Of the arginine
substitutions examined, only the α1R131 mutations
caused a marked increase in the IC50 value of strych-
nine, with a 20-fold change upon lysine and a 360-fold
change upon alanine incorporation. In contrast, the
α1R65 and α1R119 mutations had only minor effects
on strychnine inhibition (4- to 7-fold reduction). Another
substitution affecting strychnine binding is α1T208A,
which led to a 60-fold shift in IC50 value. Together, these
results indicate that within the binding pocket strych-
nine interacts with several of the residues required for
glycine binding.
Model of the Binding Pocket
of the Homooligomeric GlyR
From our previous model of the α1 GlyR binding
pocket, several residues located at the interface of two
adjacent α1 subunits had been suggested to contribute
to glycine binding (Laube et al., 2002). Specifically,
three arginines located on the − side (α1R65, α1R119,
and α1R131) and five residues on the + side (α1Q155,
α1E157, α1Y197, α1H201, and α1F207) appeared to be
good candidates for interactions with the α-carboxyl
and α-amino groups of the agonist. Considering pre-
viously described effects of α1 substitutions on glycine
Neuron
730Figure 2. Glycine Responses and Strychnine Inhibition of Homopentameric wt and Mutant α1 GlyRs and Deduced Ligand Docking Models
In vitro transcribed wt or mutant α1 cRNAs were injected into Xenopus laevis oocytes. Membrane currents elicited by superfusion of increas-
ing glycine concentrations were recorded after 1–2 days. Data points represent means ± SD (bars shown when larger than symbols) from 4
to 12 experiments, normalized to the corresponding Imax or, in the case of inhibition curves, IEC50 of glycine. (A) Glycine dose responses
recorded from wt α1 (red squares) and mutant α1R65K (white circles), α1R65A (black circles), α1R119K (white diamonds), α1R119A (black
diamonds), α1R131K (downward-pointing white triangles), and α1R131A (downward-pointing black triangles) GlyRs. (B) Strychnine inhibition
curves obtained with oocytes injected with wt α1 (red squares) and mutant α1F63A (upward-pointing white triangles), α1R131K (downward-
pointing white triangles), α1R131A (downward-pointing black triangles), and α1T208A (Xs) cRNAs. Data are plotted as a fraction of the glycine
current elicited in the absence of strychnine. (C) Model of glycine binding at the interface of two adjacent GlyR α1 subunits. The α-carboxyl
group is ligated by the positively charged α1R65 on the − side and builds hydrogen bonds with α1T204 and α1Y202 on the + side of the
interface. On the + side, the α-amino group is stabilized by the γ-carboxyl group of α1E157 and via cation-π interactions with α1F159 and
α1F207. (D) Close-up view of the modeled α1 binding pocket docked with strychnine. The guanidinium group of α1R131 interacts with oxygen
O24 of strychnine, and the protonated nitrogen N19 points toward α1E157. This positive charge is further stabilized via a cation-π interaction
with α1F207; α1Y202 stabilizes strychnine's aromatic ring. In (C) and (D), the backbones of the α1 subunits are illustrated in a ribbon
representation (green, + side; blue, − side) and are only partially shown when overlapping with residues. Key residues are highlighted by a
stick representation, in which white sticks represent carbon atoms, red sticks represent oxygen atoms, and blue sticks represent nitrogen
atoms. Aromatic residues lining the binding pocket are depicted in orange. The aromatic side chains α1F63 and α1F159 stabilize the guani-
dinium groups of α1R65 and α1R131, respectively. Main interactions with the ligands are further indicated by dashed lines. Note that both
binding pockets are not presented in exactly the same orientation to enable the best view on receptor ligand interactions.and strychnine affinity (Laube et al., 2000; Rajendra et n
cal., 1995; Schmieden et al., 1993; Vandenberg et al.,
1992a; Vandenberg et al., 1992b), we generated a re- c
gfined three-dimensional model of the ligand binding site
of the α1 GlyR. Glycine was docked into the binding i
ipocket followed by several energy minimization runs
(for details, see Experimental Procedures). In the low- (
Cest-energy docking mode, glycine’s α-carboxyl group
was orientated toward the +, and the α-amino group t
ttoward the –, sides of the binding pocket. Residues
α1F63, α1R65, α1E157, α1F207 (this study), α1F159, r
αα1K200, α1Y202, and α1T204 (Rajendra et al., 1995;
Schmieden et al., 1993; Vandenberg et al., 1992b), p
mwhose mutation severely affects the glycine EC50 value
(55- to 8600-fold), were assumed to contribute to ago- 1ist binding. Figure 2C shows this model with glycine
omputationally docked into the binding site. The main
onclusion resulting from this improved model is that
lycine bridges the interface of adjacent subunits via
ts α-amino and α-carboxyl groups by mainly interact-
ng with two oppositely charged side chains at the +
α1E157) and − (α1R65) sides, respectively (Figure 2C).
onsistent with this mode of binding, the effects of
he isofunctional mutations α1R65K and α1E157D on
he glycine EC50 value were smaller than those with the
espective alanine substitutions, indicating that the
-carboxyl and α-amino groups of glycine are ionically
aired with these residues. The increased efficacy at
utation α1E157D of the partial agonist taurine (Table
), which has a longer main chain that compensates
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731that of the reduced side chain length of the introduced
aspartate, is also in accordance with a crucial role of
α1E157 in directly ligating agonists. The α-carboxyl
group of glycine further interacts via two additional
H-bridges with the hydroxyl groups of α1Y202 and
α1T204; hence, glycine binding is strongly reduced
upon the substitutions α1Y202F (Rajendra et al., 1995)
and α1T204A (Rajendra et al., 1995; Vandenberg et al.,
1992b). Two cation-π interactions with the aromatic
side chains of α1F159 and α1F207 are predicted to sta-
bilize the α-amino group of glycine (Figure 2C). Indeed,
the isofunctional substitutions α1F159Y and α1F207Y
have been shown to increase or to not affect apparent
glycine binding affinities (Laube et al., 2000; Schmieden
et al., 1993), whereas alanine substitutions at these po-
sitions nearly abolished glycine binding (this study; and
B.L., unpublished data). The proper side chain orienta-
tions of the crucial residues α1R65 and α1E157 are pre-
dicted to be stabilized by additional cation-π interac-
tions with α1F63 and α1Y202, and by a salt bridge with
α1K200, respectively (Figure 2C).
Using computational docking, we also identified spe-
cific interactions for the antagonist strychnine within
the binding pocket (Figure 2D). In contrast to glycine
binding, strychnine binding is most strongly affected
upon substitution of α1R131, whereas substitutions of
α1R65 have only a modest effect. We therefore propose
that the oxygen at position 24 of strychnine directly in-
teracts with the guanidinium group of α1R131. The pos-
itively charged N19 of strychnine, which is protonated
at physiological pH (Becker, 1992), mainly interacts with
the negatively charged side chain of α1E157 and is also
stabilized by cation-π interactions with α1F159 and
α1F207. An additional important interaction exists be-
tween the benzene ring of strychnine and the aromatic
side chain of α1Y202, which are likely to form a π-π
bond. Interestingly, in contrast to what is found for gly-
cine binding, loss of the hydroxyl group of α1Y202 in
the α1Y202F mutation does not affect strychnine bind-
ing (Rajendra et al., 1995), consistent with a pure π-π
interaction as predicted from our model. Notably, major
differences in the orientation of side chains or in the
overall structure of the backbone are not detectable
between the glycine- and the strychnine-ligated bind-
ing pockets. Only residue α1Y202 is pushed toward the
outside of the pocket upon strychnine binding, result-
ing in a more open conformation of the second Cys-
loop. The interactions of α1F63 with α1R65, and of
α1K200 with α1E157, are maintained in the strychnine
bound model, similar to the situation obtained after gly-
cine binding. In summary, our model allows us to dock
agonists and antagonists into the binding site located
at the intersubunit crevice in orientations consistent
with our mutational data. However, a pronounced reori-
entation of a side chain emerges only in a single case,
α1Y202.
Rescue of Mutant 1 GlyRs by Coexpression
with a wt  Subunit
In the adult spinal cord, synaptic GlyRs consist of α
and β subunits. The glycine EC50 value of the hetero-
oligomeric α1β wt receptor is known to be similar to
that of homooligomeric α1 GlyRs (Kuhse et al., 1993).To evaluate whether the β subunit also contributes to
ligand binding, we expressed the low-affinity α1R65A
and the α1E157D mutants together with the wt β sub-
unit. For heterooligomeric GlyR expression, α1 and β
cRNAs were mixed at a ratio of 1:4 to minimize genera-
tion of homopentameric α1 receptors. Surprisingly, the
β subunit was able to rescue the dramatic increase in
glycine EC50 value caused by the α1 substitutions (Fig-
ure 3A) to nearly α1β wt levels (Table 2). In contrast to
the homooligomeric α1R65A and α1E157D GlyRs,
which both displayed no current saturation at 300 mM
glycine (EC50 valuesR 250 mM; see Table 1), the heter-
ooligomeric α1R65Aβ and α1E157Dβ receptors showed
maximal currents already at 5–10 mM glycine. Most as-
tonishing was the rescue for the α1E157D mutant,
which gave only small currents as a homopentamer but
full current flow upon coexpression with the β subunit
(Figure 3A). Moreover, coexpression of the α1R65A mu-
tant with the β subunit resulted in a heterooligomeric
receptor with a glycine EC50 of 0.65 ± 0.13 mM, i.e., a
value that was not significantly different from that of wt
α1β GlyRs (EC50 of glycine 0.48 ± 0.15 mM). Similar
results were obtained when the α1E157D mutant was
coexpressed with the wt β subunit (EC50 value 0.83 ±
0.26 mM) (Figure 3B). Thus, the overall rescue effects
of the β subunit on apparent glycine affinity were 380-
fold and 300-fold for the α1R65A and α1E157D substi-
tutions, respectively. These results indicate that the β
subunit has a dominant role in agonist binding to het-
erooligomeric GlyRs.
To examine whether the β subunit is also able to res-
cue strychnine binding to mutant α1 subunits, we coex-
pressed the wt β subunit with α1 mutants that displayed
strongly reduced strychnine affinities (α1R131Aβ and
α1E157Dβ). These substitutions are located at the −
and + sides of the interface, respectively. At wt homo-
and heterooligomeric GlyRs, strychnine IC50 values are
almost identical (α1, IC50 = 36 ± 10 nM and α1β, IC50 =
32 ± 8 nM; see Tables 1 and 2). Interestingly, upon coex-
pression with the β subunit only α1E157D was rescued
to wt levels (IC50 = 35 ± 10 nM), whereas the α1R131Aβ
GlyR retained a strongly reduced strychnine affinity
(IC50 = 20000 ± 4000 nM) (Figure 3C), although its gly-
cine response was comparable to that of wt α1β GlyRs
(see Table 1). These results suggest a differential contri-
bution of subunit interfaces to strychnine binding at
heterooligomeric α1β GlyRs.
 Subunit Residues Implicated in Ligand Binding
To further investigate the role of the β subunit in ligand
binding, we replaced residues of the β subunit (βR86,
βR154, βE180, βK223, βY225, βK226, βY231) by alanine,
which are homologous to the ligand binding residues
of the α1 subunit (α1R65, α1R131, α1E157, α1K200,
α1Y202, α1N203, α1F207, respectively). Then, mutant β
and wt α1 cRNAs were coinjected at a ratio of 4:1. To
distinguish between homo- and heteromeric receptors,
all glycine dose-response curves were recorded in the
presence of 100 µM picrotoxinin, which inhibits homo-
but not heteropentameric GlyRs (Pribilla et al., 1992).
Most of the mutant β subunits generated heterooligom-
eric receptors with reduced apparent glycine affinities










































Figure 3. Rescue of α1 Mutant GlyRs by Coexpression with the wt α
β Subunit β
(A) Glycine responses of homo- and heterooligomeric GlyRs. Ho- i
mopentameric α1R65A and α1E157D GlyRs show no current satu- t
ration at 300 mM glycine, and current flow is strongly reduced for
αthe α1E157D substitution. Upon coexpression of both mutant α1 βand the wt β subunit, glycine responses are rescued to almost wt
slevels, with current saturation occurring at 5–10 mM glycine. Note
that current flow is also restored with the α1E157Dβ mutant. Ago- h
nist concentrations are given in mM. l
(B) Glycine dose-response curves for homooligomeric α1R65A i
(black circles) and α1E157D (black diamonds) receptors, and heter-
kooligomeric α1R65Aβ (white circles) and α1E157Dβ (white dia-
amonds) receptors. Note leftward shift of glycine dose-response
tcurves with both heterooligomeric receptors. Data points represent
means ± SD (shown when larger than symbols) from six experi- t
ments, normalized to the corresponding Imax of glycine. t
(C) Strychnine inhibition of wt and mutant α1 (white bars) and α1β o
(gray bars) GlyRs. Glycine was applied at the corresponding EC50 fvalue, and inhibition by 100 nM strychnine was determined. Data
sare presented as means ± SD. Note that coexpression of the β
tsubunit rescues strychnine inhibition only for the α1E157D but not
the α1R131A subunit. o
cn glycine EC50 value were obtained for α1βR86A and
1βE180A GlyRs (EC50 = 5.7 ± 2.1 mM and 2 ± 0.7 mM,
espectively). More modest changes in the glycine EC50
alue (2- to 3-fold) were observed with the following
utant receptors: α1βR154A, α1βK223A, α1βY225A,
nd α1βY231A. In contrast, the βK226A substitution
ad no significant effect on apparent glycine affinity.
ince βR86 and βE180 are homologous to α1R65 and
1E157, our results highlight the importance of these
harged side chains for agonist binding to both homo-
nd heterooligomeric GlyRs. Furthermore, they under-
ine the important contribution of the β subunit to ligand
inding in α1β receptors.
We also examined strychnine antagonism with the het-
rooligomeric mutant GlyRs. Substitutions α1βE180A,
1βK223A, and α1βY225A resulted in significant reduc-
ions of the IC50 value of strychnine (3- to 6-fold). In
ontrast, the α1βR154A, α1βK226A, and α1βY231A GlyRs
isplayed no detectable changes in antagonist affinity,
ith IC50 values similar to wt (Figure 4B and Table 2).
hese results suggest that the β subunit of the GlyR is
mportant for both agonist and antagonist binding.
odels of the Heterooligomeric Subunit Interfaces
or generating models of the heterooligomeric subunit
nterfaces, one α1 subunit of the α1α1 dimer (Figure 1B)
as replaced by a β subunit either on the + or the −
ide, thereby creating α1β and βα1 interfaces, respec-
ively. Since all residues crucial for ligand binding to
he α1 subunit are conserved in the β polypeptide, we
ssumed that homologous residues in both subunits
re involved in ligand binding. Modeling of the het-
romeric interfaces revealed that the α-carboxyl and
-amino groups of glycine are consistently stabilized
ia ionic interactions with the β residues R86 at the α1β
data not shown) and E180 at the βα1 (Figure 4C) inter-
aces, respectively. Hence, the heterooligomeric inter-
aces bind the amino and the carboxyl group of glycine
hrough the combinations α1E157/βR86 and βE180/
1R65 of the α1β or βα1 dimers, respectively. Further
tabilization may be provided by the + side residues
1F159, α1K200, α1Y202, α1T204, and α1F207 at the
1β interface and by the homologous β side chains
F182, βK223, βY225A, βT228, and βY231 at the βα1
nterface. This is consistent with the results obtained in
his study, where substitutions of βR86 (homologous to
1R65) at the − side of the binding pocket, and of
E180 (homologous to α1E157) at the corresponding +
ide, caused increases in the glycine EC50 value of the
eterooligomeric GlyR. Because the enthalpies calcu-
ated for glycine binding to both interfaces are very sim-
lar (H = −19.6 kcal/mol [α1β] versus H = −19.2 [βα1]
cal/mol), we suppose that glycine binds with similar
ffinity at both interfaces. This assumption is consis-
ent with both the rescue of α1 binding site substitu-
ions seen upon coexpression of the wt β subunit and
he increased glycine EC50 values found for substitution
f β residues at both the + and − sides of subunit inter-
aces. Notably, the effects of β subunit substitutions on
trychnine inhibition are different. Here, coexpression of
he β subunit rescued strychnine binding only in case
f α1 substitutions that are located at the + side, indi-
ating a preferential binding of strychnine to the βα1
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733Table 2. Agonist and Antagonist Response Properties of Heterooligomeric α1β GlyRs
Glycine Strychnine
cRNA Injected EC50 [mM] (n) nH IC50 [nM] (n)
wt α1β 0.48 ± 0.15 (8) 1.5 ± 0.2 32 ± 8 (5)
α1R65Aβ 0.65 ± 0.13 (6) 1.5 ± 0.2 ND
α1R131Aβ 0.57 ± 0.20 (5) 1.0 ± 0.3* 20000 ± 4000* (6)
α1E157Dβ 0.83 ± 0.26* (6) 1.5 ± 0.1 35 ± 10 (5)
α1βR86A 5.7 ± 2.1* (6) 1.0 ± 0.2* ND
α1βR154A 0.93 ± 0.23* (8) 1.5 ± 0.2 27 ± 9 (5)
α1βE180A 2.0 ± 0.8* (9) 1.1 ± 0.3* 210 ± 60* (5)
α1βK223A 1.2 ± 0.3* (7) 1.6 ± 0.1 100 ± 14* (4)
α1βY225A 1.6 ± 0.5* (5) 1.5 ± 0.4 200 ± 30* (4)
α1βK226A 0.7 ± 0.2 (5) 1.5 ± 0.2 23 ± 9 (4)
α1βY231A 1.0 ± 0.2* (6) 1.3 ± 0.2 28 ± 16 (4)
(α1β)T NF (20) — ND
(α1β)T + α1E157D R250* (6) ND ND
(α1β)T + α1R65A R250* (6) 2.7 ± 0.5* ND
(α1β)T + β 0.56 ± 0.22 (13) 1.6 ± 0.4 ND
Data are presented as means ± SD and marked with an asterisk when significantly different (p < 0.01) from wt receptors (Student's t test).
ND, not determined; NF, not functional; n, number of experiments.Figure 4. Glycine Responses and Strychnine Inhibition of Heterooligomeric GlyRs Containing Mutant β Subunits
(A) Glycine dose-response curves for wt α1β (red squares), α1βR86A (black circles), α1βE180A (black diamonds), α1βK223A (Xs), and
α1βY225A (upward-pointing black triangles) GlyRs.
(B) Strychnine inhibition curves for wt α1β (red squares) and the mutant α1βE180A (black diamonds), α1βK223A (Xs), and α1βY225A (upward-
pointing black triangles) GlyRs. Data points represent means ± SD (bars shown when larger than symbols) from four to five experiments,
normalized to the corresponding Imax or, in the case of inhibition curves, IEC50 of glycine.
(C) Model of the heterooligomeric βα1 interface docked with the agonist glycine. Glycine interacts with βE180 at the + side, and α1R65 at the
− side, of the binding pocket. Additional stabilization is provided by the hydrogen bonds with βY225 and βT228 located on the − side, and
βF182 and βY231 on the + side, of the interface.
(D) Model of the βα1 interface ligated with strychnine. On the + side, the side chains of βE180, βK223, βY225, and βY231 interact with
strychnine. On the − side, residue α1R131 stabilizes the antagonist. Note similarity of docking modes shown in (C) and (D) to those presented
for α1 GlyRs in Figures 2C and 2D.
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734interface (Figure 4D). This is consistent with β subunit
mutations not affecting strychnine potency when intro-
duced at the − side and is also in agreement with our
enthalpy calculations, which predict that strychnine
binding at the α1α1 and βα1 interfaces (H = −38.2 and
−41.6 kcal/mol, respectively) is energetically favored to
binding at the α1β interface (H = −28.1 kcal/mol).
Stoichiometry of Heterooligomeric 1 GlyRs
The heterooligomeric GlyR is thought to be composed
of three α1 and two β subunits (Langosch et al., 1988).
However, when comparing the glycine EC50 values of
heterooligomeric receptors that carried mutations of
homologous ligand binding residues in either the α1 or
the β subunit, we realized that homologous substitu-
tions in the two subunits differentially affected the gly-
cine response. Specifically, the α1R65A substitution
caused an increase in glycine EC50 value (0.65 ± 0.13
mM) that was significantly smaller than that found for
the homologous βR86A mutation (EC50 = 5.7 ± 2.1 mM)
(Table 2), suggesting that the β subunit determines ago-
nist affinities. To unravel whether this reflects a higher
copy number of β versus α subunits, we generated a
concatemeric subunit fusion protein, in which the C ter-
minus of the α1 subunit was linked to the N terminus of
the β subunit via a 7-fold alanine-glycine-serine repeat.
Expression of this tandem construct (αβ)T in oocytes
alone gave no significant current flow (Figure 5A). Fur-
thermore, coexpression of the concatemeric subunit
F
(
with mutant α1 subunits (α1R65A and α1E157D) gener- s
ated channels with pharmacological properties charac- l
oteristic of homooligomeric α1 receptors (Table 2), e.g.,
(glycine EC50 values similar to those of α1R65A and
iα1E157D homomeric GlyRs (see Table 1). In contrast,
lcoexpression of (αβ)T with the wt β subunit resulted in f
a functional receptor with an EC50 of 0.56 ± 0.22 mM P
(Table 2), i.e., a value identical to that of wt α1β GlyRs r
r(EC50 = 0.48 ± 0.15 mM). This is consistent with the
(subunit stoichiometry of the heterooligomeric GlyR be-
cing 2α1:3β.
tTo further establish the subunit composition of het-
c
erooligomeric GlyRs by an independent biochemical c
approach, we metabolically labeled α1β receptors with a
s[35S]methionine by coexpressing the α1 subunit with a
rHis-tagged β subunit. The radiolabeled GlyRs were
cthen purified by metal affinity chromatography from
pdigitonin extracts of the oocytes and analyzed by re-
ducing SDS-PAGE (Sadtler et al., 2003). Figure 5B shows
the 35S-labeled subunit bands visualized by phosphor- u
mimaging. Quantification revealed that the coisolated non-
tagged α1 subunit band contained 1.38-fold more s
gradioactivity than the His-tagged β polypeptide (Figure
5B). This ratio is very close to the theoretical value of
u1.42 calculated for a stoichiometry of 2α1:3β subunits,
based on 17 and 8 methionine residues per mature α1 m
rand β subunit, respectively (α1/β = 34 × M/24 × M). To
display the entire amounts of α1 and β subunits synthe- f
ssized from an injected 5-fold excess of β over α1
cRNAs, we also coexpressed and purified His-tagged a
2versions of both subunits. Quantification yielded a sim-
ilar ratio of 1.35 of α1 to β subunit radioactivities (data t
mnot shown). The almost identical ratios obtained by
both protocols suggested that all recombinant α1 sub- wigure 5. Subunit Stoichiometry of the Heterooligomeric GlyR
A) Glycine currents recorded from oocytes expressing the tandem
ubunit (αβ)T either alone or together with the wt β subunit. Note
ack of current responses in (αβ)T singly but not β coexpressing
ocytes. Glycine concentrations are indicated in mM.
B) Metabolic labeling of α1β GlyRs. Xenopus oocytes coexpress-
ng a His-tagged β with a nontagged α1 subunit were metabolically
abeled with [35S]methionine. Recombinant GlyRs were purified
rom oocyte extracts on Ni2+-NTA Agarose and subjected to SDS-
AGE. Gel lanes were scanned with a PhosphoImager (left, with
espective molecular masses of the GlyR subunits), and the relative
atio of the α1 to β subunit radioactivity was determined (1.38).
C) Surface labeling of heterooligomeric α1β GlyRs. Xenopus oo-
ytes coexpressing metabolically labeled His-tagged β and non-
agged α1 subunits were surface labeled with biotin. Receptor
omplexes were isolated from a digitonin extract of ten pooled oo-
ytes by Ni2+-NTA Agarose and streptavidin bead chromatography
nd subjected to SDS-PAGE (left, lane 2). Nonbiotinylated oocytes
howed no labeling (left, lane 1). Quantification of 35S-labeled
adioactivities revealed that the coisolated nontagged α1 subunit
ontained 1.44-fold more radioactivity than the His-tagged β poly-
eptide (right).nits were associated with β subunits under the experi-
ental conditions used. Moreover, these results further
upport an 2α1:3β subunit stoichiometry of heterooli-
omeric GlyRs.
To exclude the possibility that intracellularly retained
nassembled or partially assembled GlyR subunits
ight contribute to the above determined α1/β subunit
atios, we also purified metabolically labeled GlyRs
rom the cell surface. In oocytes, GlyRs have been
hown to reach the plasma membrane only when fully
ssembled into functional channels (Büttner et al.,
001) and to be internalized as pentamers upon ubiqui-
ination (Sadtler et al., 2003). Intact oocytes expressing
etabolically labeled α1 and His-tagged β subunits
ere therefore surface labeled with biotin, and GlyRs
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735were purified from digitonin extracts of ten pooled
cells by sequential Ni2+-NTA Agarose and streptavidin
bead chromatography. After SDS-PAGE, quantification
of 35S-radioactivities in the subunit bands by phos-
phorimaging again resulted in an α1/β ratio of 1.44 (Fig-
ure 5C). We therefore conclude that the α1 and β GlyR
subunits assemble at an invariant stoichiometry of
2α1:3β.
Discussion
In this study, we present a detailed mutational analysis
of amino acid residues implicated in ligand binding to
homo- and heterooligomeric GlyRs. Our data show that
two conserved, oppositely charged residues located at
the + and − sides of GlyR subunit interfaces (R65 and
E157 in α1, R86 and E180 in β) provide the key ionic
interactions with the α-amino and α-carboxylate groups
of bound glycine. In addition, our results disclose a role
of the β subunit in agonist binding to heterooligomeric
GlyRs by demonstrating rescue of low-affinity α1 sub-
unit binding mutants upon coexpression with the
“structural” β polypeptide. These rescue experiments
as well as our analysis of a tandem α1β construct and
metabolic labeling of the recombinant α1β GlyR are
consistent with a 2α1:3β subunit stoichiometry of het-
erooligomeric GlyRs. Our results imply that the β sub-
unit is the predominant ligand binding subunit of syn-
aptic GlyRs.
Conserved Amino Acid Binding Mode
in Ligand-Gated Ion Channels
In all members of the Cys-loop receptor family, neuro-
transmitter binding is believed to require several dis-
continuous segments of the N-terminal extracellular
regions of two adjacent subunits, which lie at the inter-
face w30 Å from the membrane (Brejc et al., 2001; Un-
win, 2003). Our mutational analysis of homo- and heter-
ooligomeric GlyRs is consistent with this concept.
Here, we show that ionic interactions at the interface of
adjacent α, or α and β, subunits are crucial for stabiliz-
ing glycine’s α-carboxyl and α-amino groups. Specifi-
cally, substitution of a conserved arginine residue at
the − side of the binding pocket (R65 in the α1, R86 in
the β subunit) caused drastic increases in the EC50
value of glycine. At the corresponding + side, mutation
of the conserved glutamate (E157 in α1, E180 in β) simi-
larly led to drastic reductions in apparent glycine affin-
ity. The effects of isofunctional replacements (α1R65K
and α1E157D) were less marked, consistent with
charged head groups at these positions being required
for glycine binding. Furthermore, the efficacy of the
partial agonist taurine was increased at the α1E157D
substitution. Apparently, the larger intercharge distance
in taurine compensated for the reduced side chain
length of aspartate.
The importance of the binding residues identified
here is further underlined by site-directed mutagenesis
experiments on other Cys-loop receptors (reviewed in
Sixma and Smit, 2003). The crucial residues α1R65 at
the − side, and α1E157 at the + side, of the GlyR α1
subunit interface are conserved not only in GlyR pro-
teins but also at the agonist binding interfaces formedby α, β, and ρ subunits of the GABAA/CR family (Figure
1A), where they provide key ionic interactions with the
α-carboxylate and γ-amino groups of bound GABA
(Cromer et al., 2002). Hence, these residues serve as
“coordinates” for ligand orientation in the binding
pocket of inhibitory ligand-gated ion channels.
Glycine is not only the principle agonist of the GlyR
but also an essential coagonist of the NMDAR. Al-
though both receptors depend on glycine for efficient
channel activation, their glycine binding sites differ in
structural organization, antagonist pharmacology, and
preference for amino acid stereoisomers (Pullan and
Powel, 1992). Mutagenesis studies and crystallography
have shown that the α-carboxyl and α-amino groups of
glycine interact with arginine (R505) and aspartate
(D714) residues located in distinct lobes of the glycine
binding pocket formed by the NR1 subunit of the
NMDAR (Furukawa and Gouaux, 2003; Hirai et al., 1996;
Laube et al., 1997). Thus, crucial determinants of gly-
cine binding to the NMDAR are similar to those in the
GlyR and are equally located at opposite sides of a pro-
tein interface.
Determinants of Agonist and Antagonist Action
Strychnine is a competitive antagonist of the GlyR that
also binds to the interface of adjacent subunits. At
the + side, high-affinity strychnine binding to homo-
oligomeric α1 GlyRs required the conserved glutamate
E157, which is crucial for stabilizing glycine’s α-amino
group. At the − side, strychnine binding was most
strongly affected upon substitution of α1R131, a resi-
due that only marginally contributes to glycine binding.
Thus, agonists and antagonists share overlapping but
not identical binding determinants at the α1 GlyR. A
different situation was found for the heterooligomeric
receptor, where strychnine binding was mainly affected
upon substituting βE180 at the +, and α1R131 at the −,
sides of the interface. However, although these charged
residues are conserved on the α1 + and on the β − side,
the respective mutations did not affect strychnine bind-
ing, consistent with a preferential interaction of strych-
nine with the βα interface. This contrasts our findings
with glycine, which does not discriminate between sub-
unit interfaces of the heteromeric GlyR. Whether this
may reflect different contributions of the α and β sub-
units to channel opening, as suggested in case of the
nAChR (Unwin et al., 2002), is not clear presently.
For the nAChR, Unwin and colleagues have proposed
a “sliding subunit” mechanism of channel opening that
postulates extensive conformational changes resulting
from agonist binding (Unwin et al., 2002). A recent study
by Celie et al. (2004), however, reports that the X-ray
structures of the agonist- and antagonist-ligated
AChBP differ only modestly. Thus, subtle conforma-
tional rearrangements of the extracellular domains may
be sufficient for channel opening. Following this con-
cept, we speculate that the different functional conse-
quences resulting from binding either agonist (glycine)
or antagonist (strychnine) might reflect differences in
the strengthening of subunit-subunit interactions (Laube
et al., 2002). Furthermore, our previous modeling pre-
dicts that, at the GlyR, the modulatory effects of Zn2+
on agonist-triggered ion flux are due to binding of the
Neuron
736metal ion at subunit interfaces (Laube et al., 2002). In m
cconclusion, modulation of subunit-subunit interactions
appears to be a general mechanism for regulating state f
itransitions within the Cys-loop receptor family.
pSubunit Stoichiometry of Heterooligomeric GlyRs
GThe observation that at heterooligomeric GlyRs both
dthe αβ and βα interfaces contribute to glycine binding
ehas important implications for our understanding of
1GlyR function. GlyR channel opening has been reported
Gto require the binding of >2 glycine molecules, as de-
sduced from detailed kinetic analysis (Beato et al., 2002;
dColquhoun and Sivilotti, 2004; Laube et al., 2000). Here,
icoexpression of mutant α1 with wt β subunits resulted
lin a full rescue of the EC50 value of glycine, whereas
ecoexpression of the wt α1 subunit with the respective
Ghomologous β mutants produced a decrease in glycine
fapparent affinity. This was an indication that in hetero-
americ GlyRs the β subunit might contribute more impor-
Gtantly to glycine binding than the α1 subunit, and hence
sthe α1:β stoichiometry might be 2:3 instead of 3:2 as
dpreviously determined (Burzomato et al., 2003; Lan-
bgosch et al., 1988). Our experiments with the (αβ)T tan-
cdem construct lend further support to this idea. When
Gexpressed alone, (αβ)T failed to produce detectable
cchannel activity, whereas coexpression with the β sub-
hunit, but not two low-affinity α1 mutants, generated
bfunctional heterooligomeric GlyRs. Again, this result is
mmost easily reconciled with two copies of (αβ)T coas-
msembling with β into a GlyR pentamer. This conclusion
ais confirmed further by our biochemical data. Upon
2metabolic labeling with [35S]methionine followed by af-
afinity purification of the recombinant α1β GlyR, the ratio
uof α1 and β subunit radioactivities was found to be very
bclose to that predicted for an α1:β stoichiometry of 2:3.
eFurthermore, radioactivity ratios proved to be invariant
iregardless whether surface biotinylated, i.e., plasma
dmembrane bound, or total GlyRs were affinity purified.
nIn conclusion, all data presented here are consistent
gwith the revised stoichiometry of 2α1:3β. The latter
implies the formation of at least one ββ interface, as
originally suggested from cross-linking experiments P
M(Langosch et al., 1988). This unique interface might
constitute a pharmacological target side on hetero- d
cmeric GlyRs, in analogy to the αγ interface of GABAARs,
which determines benzodiazepine pharmacology (Cro- b
rmer et al., 2002).
The discrepancy between the subunit stoichiometry d
bof heterooligomeric GlyRs determined here (2α1:3β)
and that reported in previous studies (3α1:2β) cannot m
ibe attributed to variations in the β subunit content of
recombinant GlyRs. Although the α1 and α2 subunits p
dcan coassemble into functional GlyRs at variable sub-
unit ratios, incorporation of the β subunit has been 1
tshown to occur only at an invariant α:β subunit stoichi-
ometry (Kuhse et al., 1993). In case of our cross-linking h
(experiments with affinity-purified GlyR (Langosch et al.,
1988), the formation of higher-order α subunit adducts e
mmay have been due to copurification of homooligo-
meric GlyRs that are present in significant amounts h
ceven in adult tissue (Chattipakorn and McMahon, 2002).
Similarly, conclusions from glycine dose-response analy- p
tses of recombinant heteromeric mutant GlyRs (Burzo-ato et al., 2003; Kuhse et al., 1993) are biased by un-
ertainties about the contribution of simultaneously
ormed homomeric receptors to the respective agonist-
nduced currents.
Our identification of the β subunit as the major poly-
eptide of heteromeric gephyrin binding, i.e., synaptic
lyRs (Meyer et al., 1995) sheds new light on the abun-
ant and widespread expression of the Glrb gene in the
mbryonic and adult mammalian CNS (Fujita et al.,
991; Malosio et al., 1991). Previously, the presence of
lyR β transcripts in brain regions known to lack
trychnine binding sites has been interpreted as evi-
ence for the existence of yet unknown strychnine-
nsensitive GlyR or GABAAR subtypes (Betz, 1991; Ma-
osio et al., 1991). Now, we propose that the Glrb gene
ncoding the major ligand binding subunit of synaptic
lyRs is widely expressed, and that the assembly of
unctional GlyRs is regulated by the developmentally
nd neuronal subtype-specific synthesis of selected
lyR α subunits. This proposal is in line with the ob-
ervation that GlyR α1 and α2 mRNAs are found den-
ritically on membrane cisternae, which are located
eneath gephyrin-positive postsynaptic membrane spe-
ializations (Racca et al., 1997). As these subsynaptic
lyR transcripts have been implicated in synapse-spe-
ific and/or activity-regulated translation processes,
eterooligomeric GlyR assembly at synaptic sites may
e controlled by local α but not β mRNA pools. Further-
ore, the revised subunit stoichiometry deduced here
ay also be relevant for GlyR anchoring to the postsyn-
ptic scaffolding protein gephyrin (Kneussel and Betz,
000). Gephyrin is a highly mosaic protein that carries
binding site for the cytoplasmatic loop of the β sub-
nit on its C-terminal E domain (Sola et al., 2004). Nota-
ly, native gephyrin is a trimer (Sola et al., 2001; Sola
t al., 2004). Hence, the three β loop sequences present
n the GlyR pentamer may interact with up to three E
omains of gephyrin and thereby allow for distinct ki-
etic states of GlyR immobilization on the subsynaptic
ephyrin lattice (Dahan et al., 2003).
athological Implications
utations in GlyR genes cause hereditary neuromotor
iseases in man and animals (Schofield, 2002). Specifi-
ally, amino acid substitutions in the α1 subunit have
een identified in patients suffering from dominant and
ecessive forms of hereditary hyperekplexia (or startle
isease). Related mouse mutants have been shown to
e deficient in either GlyR α1 or β subunit function. The
utant spastic (spa) has an intronic insertion of a repet-
tive element in the Glrb gene that leads to inefficient
rocessing of the β pre-mRNA, and hence strongly re-
uced levels of β subunit protein (Kingsmore et al.,
994; Mulhardt et al., 1994). Consistent with this inser-
ion being causal for the disease phenotype, spa mice
ave been rescued by a rat β subunit transgene
Hartenstein et al., 1996). Recently, a human startle dis-
ase phenotype has been associated with a missense
utation in Glrb that reduces the apparent affinity of
eteromeric GlyRs (Rees et al., 2002). This mutation
auses a 3.4-fold increase in the EC50 for glycine com-
ared to wt α1β GlyR. The data presented here suggest
hat yet unclassified forms of hyperekplexia may in-
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737volve other mutations in the human Glrb gene, which
directly affect ligand binding to αβ or βα subunit inter-
faces.
Experimental Procedures
Expression of Mutant GlyRs and Electrophysiological Recording
Mutations were introduced into the human α1 and β subunit cDNAs
subcloned in the pNKS2 vector by using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene). All substitutions were con-
firmed by DNA sequencing. cRNAs of mutant and wt GlyRs were
synthesized and injected as described previously (Laube et al.,
2000). For the expression of heterooligomeric GlyRs, a α1:β cRNA
ratio of 1:4 was used. Two-electrode voltage-clamp recording of
whole-cell currents was performed in Ringer’s solution (Laube et
al., 2000) at a holding potential of −70 mV (or −40 mV at high ex-
pression levels). Dose-response curves for the agonists glycine and
taurine were generated by measuring the inward current elicited by
increasing agonist concentrations, whereas antagonist inhibition
curves were obtained by coapplying glycine at a concentration cor-
responding to the respective EC50 value with increasing concentra-
tions of the antagonist strychnine. For data analysis, agonist-
induced peak currents (I) were normalized to the maximal current
value (Imax) and fitted with the Hill equation as described (Wittekindt
et al., 2001). To determine half-maximal effective antagonist con-
centrations (IC50) from inhibition curves, results were fitted by the
following equation: I = Imax((1/B)nH/((1/B)nH + (1/C)nH)), where I cor-
responds to the current obtained, Imax corresponds to the maximal
agonist-induced current, B corresponds to the concentration of the
antagonist, and nH corresponds to the Hill coefficient. Experimental
values are presented as the mean ± SD of peak current responses;
significant differences were identified by Student’s t test.
Molecular Modeling of GlyR N-Terminal Domains
Molecular modeling was done by using the SYBYL 6.9 program
(Tripos Associates, St Louis, MI). The sequence alignment of the
extracellular domains of the GlyR α1 and β subunits with AChBP
was taken from Brejc et al. (2001) and used with some minor
changes (see Figure 1A). Based on the crystal structure of AChBP
(Brejc et al., 2001); Brookhaven Protein Data Bank entry 1I9B), we
constructed the Cα framework of GlyR α1 and β subunits by using
structurally conserved regions (SCRs), which mainly correspond to
the α helices and β sheets of the AChBP structure. However, in the
very N-terminal region the α helix present in AChBP was aligned to
the SDFLDKL sequence of the GlyR α1 subunit, in agreement with
the hydrophobic residues FL..L. and IL..I, respectively. Missing
peptide fragments were then extracted from the Sybyl Protein Da-
tabase within COMPOSER and joined to the SCRs. The following
operations were performed by using the Tripos force field and Koll-
man all-atom charges. After addition of all hydrogen atoms, the
resulting structure was subjected to molecular dynamic (MD) simu-
lation runs (NTV ensemble, 300 K) for 100 to 1000 fs and energy
minimized in the absence of solvent (Powell method; gradient 0.1
kcal/mol * A). This procedure was repeated until a minimum in en-
ergy was reached. Then, the respective ligands were introduced
into the binding pocket of the wt receptor by positioning them ide-
ally with the help of DOCK in a conformation that closely matched
that of the ligands bound in AChBP (Celie et al., 2004). The indivi-
dual ligand protein complexes were subjected to MD simulation in
Sybyl (version 6.9) using the TRIPOS force field to achieve optimal
configuration for up to 100 fs. In case of alternative docking confor-
mations, the energetically lowest was chosen. To produce the final
structures, the MD was subsequently minimized with the Powell
algorithm until an energy gradient of 0.01 kcal/mol was reached.
The resulting structures were used to evaluate changes in binding
site interactions caused by mutation of binding site residues.
Construction of a Tandem 1 cDNA
A concatemeric GlyR polypeptide encompassing the human α1
and β subunits, (αβ)T, was generated by expressing a tandem cDNA
subcloned into the pNKS2 vector. In this construct, the C terminus
of the α1 subunit was connected to the N terminus of the β subunit
via a linker consisting of a 7-fold Ala-Gly-Ser repeat encoded bythe nucleotide sequence (GCT GGA AGT) (Zhou et al., 2003). The
α1 subunit cDNA in the pNKS2 vector was digested with the re-
striction enzymes AatII and NotI, resulting in a loss of the last four
amino acids at the C terminus. The β subunit cDNA insert was ex-
cised from the pNKS4 vector with the restriction enzymes BbsI and
NotI, thereby deleting the signal peptide and the first amino acid.
The missing nucleotides were restored within the linker flanked by
an AatII site at the 5# and a BbsI restriction site at the 3# end of the
coding sequence. Finally, both the linker and the β subunit cDNA
were ligated into the α1 pNKS2 vector sequence.
Subunit Composition of Metabolically Labeled 1 GlyRs
For the biochemical determination of subunit stoichiometry, oo-
cytes coinjected with wt α1 or His-tagged α1 and His-tagged β
subunit cRNAs at a ratio of 1:4 were metabolically labeled by over-
night incubation with [35S]methionine as described previously
(Sadtler et al., 2003). After an additional 24 hr chase interval, a
digitonin (1% [w/v]; Sigma-Aldrich, München, Germany) extract
was prepared, and GlyRs were natively purified by Ni2+-NTA chro-
matography as described (Nicke et al., 1998).
For isolating plasma membrane bound α1β GlyRs, oocytes coin-
jected with wt α1 and His-tagged β subunit cRNAs (ratio 1:4) and
metabolically labeled as detailed above were chased with 10 mM
methionine for 36 hr and then exposed for 30 min at ambient tem-
perature to the cleavable biotinylation reagent sulfo-NHS-SS-biotin
(Pierce, Bonn, Germany) at 10 mg/ml in oocyte phosphate-buffered
saline (PBS) (30 mM phosphate, 110 mM NaCl, 1 mM CaCl2, 1 mM
MgCl2 [pH 8.0]). Biotinylated cells were washed in oocyte PBS and
lysed in phosphate buffer (0.1 M [pH 8.0]), containing dodecylmal-
toside (0.2% [w/v]; Calbiochem, Schwalbach/Taunus, Germany)
and 50 mM iodoacetamide, and α1β complexes were natively puri-
fied via the His-tagged β subunit by Ni2+-NTA affinity chromatogra-
phy. Bound α1β complexes were released by two subsequent in-
cubations, each for 15 min at 37°C, with modified RIPA buffer (1%
NP40, 0.5% deoxycholic acid, 0.1% SDS, 150 mM NaCl, 10 mM
EDTA) supplemented with 250 mM imidazole-HCl (pH 7.2). After
5-fold dilution with phosphate buffer, biotinylated α1 and His-
tagged β subunits were captured by incubation overnight at 4°C
with ImmunoPure Immobilized Streptavidin (Pierce, Bonn, Ger-
many), followed by washing of the resin with 0.2% dodecylmalto-
side in phosphate buffer. Bound proteins were released by incuba-
tion for 5 min at 95°C in SDS sample buffer containing 50 mM
dithiothreitol (DTT).
The purified GlyR was separated on 10% SDS-PAGE gels, which
were fixed, dried, and exposed to PhosphorImager screens. The
radioactivity of individual polypeptide bands was quantified using
a PhosphorImager (Molecular Dynamics) and evaluated using the
software package ImageQuant.
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